TTRX 株価分析 — Turn Therapeutics Inc. Common Stock (Healthcare >> Biotechnology)
TTRX に関するよくある質問
TTRXのPER(株価収益率)は?
Turn Therapeutics Inc. Common Stock(TTRX)は現在PER 1,016.17倍で取引されています。
TTRXのROE(自己資本利益率)は?
Turn Therapeutics Inc. Common StockのROEは-62.71%です。
TTRXの配当利回りは?
Turn Therapeutics Inc. Common Stockの配当利回りは0.00%です。
TTRXの品質スコア(Quality Score)は?
当社のAIはTTRXの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
TTRXは今が買い時ですか?
当社AIのタイミングスコアは100点中87点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
TTRXはどのセクターに属しますか?
Turn Therapeutics Inc. Common StockはHealthcare >> Biotechnologyセクターに分類されます(NASDAQ市場)
TTRX AI Analysis Summary
Our AI summary for TTRX: Turn Therapeutics Inc. Common Stock (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 1,016.17, ROE of -62.71%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 87/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 9.43
Price
-0.09
(-0.95%)
Day Change
|
|
|---|
TTRX, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) but テクニカルスコアは ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/Eが高い。割高銘柄。
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
38% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 88 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 9.43 |
| PBV / Sector |
46.36 / 44,105.10
|
| Earning Per Share | -0.13 |
| PE / Sector |
1,016.17 / 19.37
GREAT
|
| PEG or PE/Growth / Sector |
N/A / 1.06
|
| Average 1M Daily Value |
0.88 M
GREAT
|
| Average 1W Daily Value |
0.39 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
50% |
| ポイントになる統計 |
|
37% |
| 配当 |
|
8% |
| 登録情報 |
| Analyze Date | 2026-08-06 08:00:49 |
| Symbol | TTRX |
| Name | TURN THERAPEUTICS INC. COMMON STOCK |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 29.79 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 283.58 / 9,702.21 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 250 N Westlake Blvd, Westlake Village, CA, United States, 91362
Phone: 818 546 4011
Website: https://turntherapeutics.com
Sector: Healthcare >> Biotechnology
Description: Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Google